stemcell
The Niche

The Niche

Knoepfler lab stem cell blog

  • Home
  • Contact
  • About Us
  • Trial search
  • Treatments
  • Report a clinic
  • RMAT List (37)
  • TED talk
  • Nature
  • Privacy
  • Stem Cell Book
  • Dragon book
  • 2019 Meetings
  • 2020 Meetings
  • Stem cells in your language

regenerative medicine meetings

Stem cell meetings 2018

List of regenerative medicine & stem cell meetings for rest of 2018

March 19, 2018 Paul Knoepfler 1

This post contains a list of the remaining regenerative medicine and stem cell meetings for 2018. If you are interested in history, here’s our first ever meetings list for way back in 2012. Here’s the 2018 list. 10th World Congress and […]

Subscribe to this Blog

Join 24,195 other subscribers

Paul KnoepflerFollow

Prof @UCDAVIS Stem cells & Kids Brain Cancer Epigenomics #CRISPR Science policy/ethics. #scicomm TED https://t.co/4XhF0V5XiZ New book on making dragons🐲https://t.co/q9ezUzZdtx

Paul Knoepfler
EricTopolEric Topol@EricTopol·
3h

My favorite papers challenge biomedical dogma. Here's my summary of the ones in 2019 that provided evidentiary shakeups (2nd annual list)
[let me know the ones I missed]

Reply on Twitter 1205952384913903616Retweet on Twitter 1205952384913903616176Like on Twitter 1205952384913903616387Twitter 1205952384913903616
pknoepflerPaul Knoepfler@pknoepfler·
13 Dec

Wow, Liveyon has stopped sales of unproven umbilical cord cells after FDA warning letter
@lauriemcginley2
https://washingtonpost.com/health/2019/12/13/california-stem-cell-company-halts-sales-after-fda-warning/ Here's my take on that warning letter & other recent FDA steps https://ipscell.com/2019/12/fda-spike-clinic-supplier-liveyon-warning-letter-notice-on-exosome-harms/ I bet @BadBatchWondery podcast also played a role #stemcells

Reply on Twitter 1205609226476777474Retweet on Twitter 12056092264767774746Like on Twitter 120560922647677747410Twitter 1205609226476777474
pknoepflerPaul Knoepfler@pknoepfler·
13 Dec

Wow, Liveyon has stopped sales of unproven umbilical cord cells after FDA warning letter
@lauriemcginley2
https://washingtonpost.com/health/2019/12/13/california-stem-cell-company-halts-sales-after-fda-warning/ Here's my take on that warning letter & other recent FDA steps https://ipscell.com/2019/12/fda-spike-clinic-supplier-liveyon-warning-letter-notice-on-exosome-harms/ I bet @BadBatchWondery podcast also played a role #stemcells

Reply on Twitter 1205609226476777474Retweet on Twitter 12056092264767774746Like on Twitter 120560922647677747410Twitter 1205609226476777474
Load More...
  • RSS - Posts
  • RSS - Comments

Recent Comments

  • Paul Knoepfler on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Bill Jones on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Miss Matadora on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Miss Matadora on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Matthew Wilgo on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms

Copyright © 2019 | Knoepfler Lab Stem Cell Blog, UC Davis, 1 Shields Ave, Davis, CA 95616. Designwork by Tradesouthwest Top